Literature DB >> 6183642

Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain.

M L Chu, J C Myers, M P Bernard, J F Ding, F Ramirez.   

Abstract

We report the cloning of five overlapping cDNAs bearing sequences specific for the human pro alpha 1(I) collagen chain. Poly-A RNA enriched for collagen sequences was purified from normal human fibroblasts and used as template to synthesize double stranded cDNA. The cDNA was inserted into the Eco RI site of pBR 322 by blunt-ending and dG:dC tailing. The clones were screened by colony hybridization using the original RNA population and the resulting five positive clones subjected to restriction endonuclease mapping analysis and DNA sequencing. These overlapping clones cover from residue 247 in the alpha chain to part of the 3' end untranslated region of the pro alpha 1(I) mRNA for a total of 3400 nucleotides.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6183642      PMCID： PMC320940          DOI： 10.1093/nar/10.19.5925

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


  19 in total

Review 1.  Structurally distinct collagen types.

Authors:  P Bornstein; H Sage
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

2.  An unusually long non-coding region in rat lens alpha-crystallin messenger RNA.

Authors:  R J Moormann; H M van der Velden; H J Dodemont; P M Andreoli; H Bloemendal; J G Schoenmakers
Journal:  Nucleic Acids Res       Date:  1981-10-10       Impact factor: 16.971

3.  Structure of the pro alpha 2 (I) collagen gene.

Authors:  J Wozney; D Hanahan; V Tate; H Boedtker; P Doty
Journal:  Nature       Date:  1981-11-12       Impact factor: 49.962

4.  Isolation and characterization of overlapping genomic clones covering the chicken alpha 2 (type I) collagen gene.

Authors:  H Ohkubo; G Vogeli; M Mudryj; V E Avvedimento; M Sullivan; I Pastan; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

5.  Isolation and characterization of a 15-kilobase genomic sequence coding for part of the Pro alpha 2 chain of sheep type I collagen.

Authors:  C D Boyd; P Tolstoshev; M P Schafer; B C Trapnell; H C Coon; P J Kretschmer; A W Nienhuis; R G Crystal
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

6.  Plasmid screening at high colony density.

Authors:  D Hanahan; M Meselson
Journal:  Gene       Date:  1980-06       Impact factor: 3.688

7.  Transformation of E. coli using homopolymer-linked plasmid chimeras.

Authors:  S L Peacock; C M McIver; J J Monahan
Journal:  Biochim Biophys Acta       Date:  1981-09-28

Review 8.  The molecular basis of disorders of human hemoglobin synthesis.

Authors:  F Ramirez; J G Mears; A Bank
Journal:  Mol Cell Biochem       Date:  1980-08-16       Impact factor: 3.396

9.  Sequence determination and analysis of the 3' region of chicken pro-alpha 1(I) and pro-alpha 2(I) collagen messenger ribonucleic acids including the carboxy-terminal propeptide sequences.

Authors:  F Fuller; H Boedtker
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

10.  Cloning a cDNA for the pro-alpha 2 chain of human type I collagen.

Authors:  J C Myers; M L Chu; S H Faro; W J Clark; D J Prockop; F Ramirez
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205
View more
  100 in total

1.  Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulation of interleukin-1.

Authors:  J Y Hsu; M Y Hsu; T Sorger; M Herlyn; E M Levine
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

2.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4.

Authors:  A E Postlethwaite; M A Holness; H Katai; R Raghow
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Regulation of collagen I gene expression by ras.

Authors:  J L Slack; M I Parker; V R Robinson; P Bornstein
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

4.  Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells.

Authors:  J P Taylor; C Cupp; A Diaz; M Chowdhury; K Khalili; S A Jimenez; S Amini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

5.  Cultured embryonic bone shafts show osteogenic responses to mechanical loading.

Authors:  G Zaman; S L Dallas; L E Lanyon
Journal:  Calcif Tissue Int       Date:  1992-08       Impact factor: 4.333

6.  Basic fibroblast growth factor as a selective inducer of matrix Gla protein gene expression in proliferative chondrocytes.

Authors:  Chantal Stheneur; Marie-France Dumontier; Claudie Guedes; Marie-Claude Fulchignoni-Lataud; Khadija Tahiri; Gerard Karsenty; Marie Thérèse Corvol
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

7.  Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes.

Authors:  M B Goldring; J Birkhead; L J Sandell; T Kimura; S M Krane
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Messenger RNA levels of lung extracellular matrix proteins during ozone exposure.

Authors:  A M Choi; C L Elbon; S A Bruce; D J Bassett
Journal:  Lung       Date:  1994       Impact factor: 2.584

9.  Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension.

Authors:  M D Botney; M J Liptay; L R Kaiser; J D Cooper; W C Parks; R P Mecham
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

10.  Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic.

Authors:  H Takagi; M S Ochoa; L Zhou; T Helfman; H Murata; V Falanga
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.